Earnings Ahead

JNJ - Johnson

158.08 -0.55 -0.35

Johnson

Johnson

About

Profile

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.


Headquarters

New Brunswick, New Jersey, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

JNJ



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform
  • Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M
  • J&J looks to continue long streak of EPS beats with Q2 results
  • J&J ordered to pay $18.8M over baby powder cancer claim, jury rules (update)
  • J&J becomes latest Big Pharma to sue over Medicare drug pricing
  • Nanobiotix partners with J&J's Janssen for radiotherapy treatment
  • Atrial fibrillation drug market expected to decline as brand therapies go generic
  • Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
  • Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
  • FDA classifies J&J electrode recall as most serious type
  • Goldman Sachs sees rays of hope in underperforming health sector
  • Bausch + Lomb buys Blink eye drops from Johnson & Johnson
  • Johnson & Johnson psoriasis pill disappoints in phase 2 trial
  • Medicare revises guidance on drug price negotiations amid lawsuits
  • Morgan Stanley shakes up its global dividend portfolio
  • J&J submits application to EMA for combination PAH drug
  • What is behind big pharma's underperformance?
  • J&J talc bankruptcy unit to establish $750M trust fund with insurers
  • Cidara gains as FDA grants fast track status for flu candidate
  • Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations

Earnings History

Date EPS / Forecast Revenue / Forecast
January 25, 2022 2.13 / 2.12 24.8B / 25.28B
October 19, 2021 2.6 / 2.35 23.34B / 23.64B
July 21, 2021 2.48 / 2.29 23.31B / 22.49B Beat!
April 20, 2021 2.59 / 2.34 22.32B / 21.98B Beat!
January 26, 2021 1.86 / 1.82 22.48B / 21.66B Beat!
October 13, 2020 2.2 / 1.98 21.08B / 20.2B Beat!
July 16, 2020 1.67 / 1.49 18.34B / 17.61B Beat!
April 14, 2020 2.3 / 2.02 20.69B / 19.73B Beat!
January 22, 2020 1.88 / 1.87 20.75B / 20.8B
October 15, 2019 2.12 / 2.01 20.73B / 20.08B Beat!
July 16, 2019 2.58 / 2.46 20.56B / 20.29B Beat!
April 16, 2019 2.1 / 2.04 20.02B / 19.61B Beat!
January 22, 2019 1.97 / 1.95 20.39B / 20.2B Beat!
October 16, 2018 2.05 / 2.03 20.35B / 20.05B Beat!
July 17, 2018 2.1 / 2.07 20.83B / 20.42B Beat!
April 17, 2018 2.06 / 2 20.01B / 19.49B Beat!
January 23, 2018 1.74 / 1.72 20.2B / 20,072M
October 17, 2017 1.9 / 1.80 19.65B / 19,283M
July 18, 2017 1.83 / 1.80 18.84B / 18,935M
April 18, 2017 1.83 / 1.77 17.77B / 18,037M
Date Price Open High Low Vol Change ER
May 26 154.35 154.69
155.27
154.2
6.5M -0.04%
May 25 154.41 156.05
156.29
153.72
6.6M -1.44%
May 24 156.66 157.08
157.14
155.92
5.0M -0.1%
May 23 156.81 157.1
158.27
156.37
5.8M -0.04%
May 22 156.87 158
159.14
156.78
5.7M -1.28%
 
May 19 158.91 158.59
159.93
158.14
6.5M 0.27%
May 18 158.48 158.66
158.93
157.56
5.2M -0.32%
May 17 158.99 159.79
160.05
157.77
6.8M -0.22%
May 16 159.34 159.06
160.25
158.53
5.6M -0.13%
May 15 159.55 160.8
161.03
158.94
5.1M -0.77%
May 12 160.78 161.36
161.56
160.01
3.9M -0.13%
May 11 160.99 161.83
162.19
159.39
5.9M -0.41%
May 10 161.65 161.2
161.97
160.06
6.8M 0.37%
May 9 161.05 161.75
162.13
160.79
5.5M -0.78%
May 8 162.31 161.99
162.57
161.34
5.0M -0.23%
May 5 162.68 162.84
163.13
161.69
5.2M 0.34%
May 4 162.13 162.68
162.9
161.25
5.1M -0.45%
May 3 162.87 165.55
166.18
162.51
5.9M -1.31%
May 2 165.03 164.34
165.48
163.55
7.5M 0.87%
May 1 163.6 163.6
164.3
162.24
4.9M -0.06%
Apr 28 163.7 162.81
163.76
162.56
6.0M 0.43%
Apr 27 163 162.9
163.41
162.13
5.7M 0.23%
Apr 26 162.62 164.09
164.39
162.24
5.5M -1.55%
Apr 25 165.18 164.31
165.35
164.15
6.3M 0.92%
Apr 24 163.68 162.69
163.8
161.87
5.3M 0.61%
Apr 21 162.69 164.44
164.97
161.97
7.0M -0.54%
Apr 20 163.58 162.43
163.82
160.96
9.5M 0.65%
Apr 19 162.53 161.99
162.68
161.17
6.8M 0.94%
Apr 18 161.01 164.25
164.69
159.65
14.6M -2.81%
Apr 17 165.67 165.74
166.24
164.94
8.0M -0.1%
Apr 14 165.84 165.97
166.12
164.06
7.2M -0.16%
Apr 13 166.11 164.18
166.33
163.8
5.6M 1.34%
Apr 12 163.92 163.94
164.84
163.1
5.8M -0.21%
Apr 11 164.27 164.42
165.28
164.04
5.9M -0.03%
Apr 10 164.32 164.63
164.84
163.64
5.4M -0.5%
Apr 6 165.15 165.99
167.23
164.8
9.6M -0.28%
Apr 5 165.61 164.37
165.66
162.76
16.7M 4.49%
Apr 4 158.49 156.97
158.97
156.59
8.3M 1.05%
Apr 3 156.85 154.95
157.01
153.94
6.8M 1.19%
Mar 31 155 153.79
155.19
153.24
9.9M 1.02%
Mar 30 153.43 153.58
153.8
152.81
4.6M 0.08%
Mar 29 153.31 152.24
153.38
152.07
6.0M 0.98%
Mar 28 151.82 152.39
153.45
151.73
6.1M -0.97%
Mar 27 153.3 154.2
154.54
153.11
6.8M 0.43%
Mar 24 152.65 151.48
152.76
150.83
5.7M 1.01%
Mar 23 151.13 151.18
151.69
150.11
9.1M 0.05%
Mar 22 151.05 153.85
154.06
151.03
7.9M -1.85%
Mar 21 153.89 154
154.13
152.17
8.4M 0%
Mar 20 153.89 152.47
154.07
152.38
7.1M 0.99%
Mar 17 152.38 154.48
154.95
152.3
20.5M -1.07%
Mar 16 154.03 153.45
154.37
152.6
7.6M -0.21%
Mar 15 154.35 152.84
154.89
152.53
7.8M 0.28%
Mar 14 153.92 153.28
154.03
151.9
8.4M 0.56%
Mar 13 153.06 152.09
155.91
151.57
10.8M 0.96%
Mar 10 151.61 151.86
153.49
151.1
8.5M 0.24%
Mar 9 151.24 153.46
153.6
150.71
7.4M -1.12%
Mar 8 152.96 153.98
154.2
152.48
6.2M -0.73%
Mar 7 154.09 156.09
156.25
153.35
7.5M -0.94%
Mar 6 155.56 154.66
155.73
154.57
8.1M 1%
Mar 3 154.02 153.37
154.12
152.84
5.7M 0%